NO20055129L - Fenylsubstituerte karboksylsyrer - Google Patents
Fenylsubstituerte karboksylsyrerInfo
- Publication number
- NO20055129L NO20055129L NO20055129A NO20055129A NO20055129L NO 20055129 L NO20055129 L NO 20055129L NO 20055129 A NO20055129 A NO 20055129A NO 20055129 A NO20055129 A NO 20055129A NO 20055129 L NO20055129 L NO 20055129L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- phenyl
- carboxylic acids
- substituted carboxylic
- ptp
- Prior art date
Links
- -1 Phenyl-substituted carboxylic acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 abstract 1
- 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 abstract 1
- 101710128896 Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46686803P | 2003-04-30 | 2003-04-30 | |
| PCT/US2004/013701 WO2004099170A2 (fr) | 2003-04-30 | 2004-04-30 | Acides carboxyliques substitues par phenyle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055129D0 NO20055129D0 (no) | 2005-11-02 |
| NO20055129L true NO20055129L (no) | 2006-01-23 |
Family
ID=33434989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055129A NO20055129L (no) | 2003-04-30 | 2005-11-02 | Fenylsubstituerte karboksylsyrer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7524878B2 (fr) |
| EP (1) | EP1620422A2 (fr) |
| JP (1) | JP2006525365A (fr) |
| KR (1) | KR20060006954A (fr) |
| CN (1) | CN1812978A (fr) |
| AU (1) | AU2004236248A1 (fr) |
| BR (1) | BRPI0409916A (fr) |
| CA (1) | CA2524235A1 (fr) |
| EA (1) | EA200501713A1 (fr) |
| MX (1) | MXPA05011536A (fr) |
| NO (1) | NO20055129L (fr) |
| WO (1) | WO2004099170A2 (fr) |
| ZA (1) | ZA200509635B (fr) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004236247B2 (en) | 2003-04-30 | 2008-11-06 | The Institutes For Pharmaceutical Discovery, Llc | Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1 B |
| AU2004274324B2 (en) | 2003-09-17 | 2009-11-05 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| EP1745014B1 (fr) | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Nouveaux composes, leur preparation et leur utilisation |
| US7968723B2 (en) | 2004-05-05 | 2011-06-28 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EA200700243A1 (ru) | 2004-07-14 | 2007-08-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения гепатита с |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| CA2578636A1 (fr) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines utilisees pour traiter l'hepatite c |
| JP2008520693A (ja) * | 2004-11-18 | 2008-06-19 | ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー | プロテインチロシンホスファターゼ阻害剤としての置換アミノ酸 |
| WO2006055708A2 (fr) * | 2004-11-18 | 2006-05-26 | The Institutes For Pharmaceutical Discovery, Llc | Acides carboxyliques a substitution heterocyclique |
| CA2587566A1 (fr) * | 2004-11-18 | 2006-05-26 | The Institutes For Pharmaceutical Discovery, Llc | Acides carboxyliques a substitution phenyle |
| DE102004060542A1 (de) * | 2004-12-16 | 2006-07-06 | Sanofi-Aventis Deutschland Gmbh | Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung |
| WO2006117657A1 (fr) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Derives de triazolone utilises comme agents anti-inflammatoires |
| CA2613365C (fr) | 2005-06-30 | 2013-08-13 | Novo-Nordisk A/S | Acides phenoxyacetiques en tant qu'activateurs de rapp-delta |
| CN101296914B (zh) | 2005-08-26 | 2012-07-18 | 盐野义制药株式会社 | 具有ppar激动活性的衍生物 |
| NZ568488A (en) | 2005-12-22 | 2011-07-29 | High Point Pharmaceuticals Llc | Phenoxy acetic acids as PPAR delta activators |
| US7989461B2 (en) | 2005-12-23 | 2011-08-02 | Amgen Inc. | Substituted quinazolinamine compounds for the treatment of cancer |
| US7943612B2 (en) | 2006-03-09 | 2011-05-17 | High Point Pharmaceuticals, Llc | Compounds that modulate PPAR activity, their preparation and use |
| WO2008033934A1 (fr) * | 2006-09-13 | 2008-03-20 | The Institutes For Pharmaceutical Discovery, Llc | Dérivés d'acides hétéroarylcarboxyliques substitués comme inhibiteurs de la ptb-1b |
| WO2008033931A1 (fr) * | 2006-09-13 | 2008-03-20 | The Institutes For Pharmaceutical Discovery, Llc | Acides carboxyliques de para-xylylène et isothiazolones utiles comme protéines tyrosine phosphatases (ptps) en particulier ptp-ib |
| WO2009005638A2 (fr) | 2007-06-27 | 2009-01-08 | Merck & Co., Inc. | Dérivés pyridylés et pyrimidinylés en tant qu'inhibiteurs de l'histone désacétylase |
| AU2008269154B2 (en) | 2007-06-27 | 2014-06-12 | Merck Sharp & Dohme Llc | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| US20110166132A1 (en) * | 2007-12-13 | 2011-07-07 | Amgen Inc. | Gamma Secretase Modulators |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| JP5752691B2 (ja) | 2009-09-29 | 2015-07-22 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 新規化合物 |
| DE102009046115A1 (de) | 2009-10-28 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 3-Phenylpropansäuren und ihre Verwendung |
| JP5814031B2 (ja) * | 2010-07-30 | 2015-11-17 | ユー・ディー・シー アイルランド リミテッド | 有機電界発光素子、及びジベンゾチオフェン構造又はジベンゾフラン構造を有する有機電界発光素子用材料 |
| CN102382037B (zh) * | 2010-09-03 | 2016-01-20 | 中国医学科学院药物研究所 | 苯丙酸类化合物及其制法和药物用途 |
| US9107983B2 (en) | 2010-10-27 | 2015-08-18 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising statins |
| US8877221B2 (en) | 2010-10-27 | 2014-11-04 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
| ES2544532T3 (es) | 2010-12-07 | 2015-09-01 | Bayer Intellectual Property Gmbh | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso |
| JP5694561B2 (ja) | 2010-12-23 | 2015-04-01 | ファイザー・インク | グルカゴン受容体モジュレーター |
| KR101638671B1 (ko) | 2011-02-08 | 2016-07-11 | 화이자 인코포레이티드 | 글루카곤 수용체 조절자 |
| DE102011007272A1 (de) | 2011-04-13 | 2012-10-18 | Bayer Pharma Aktiengesellschaft | Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung |
| WO2012170417A2 (fr) | 2011-06-06 | 2012-12-13 | Warsaw Orthopedic, Inc. | Procédés et compositions pour améliorer la croissance osseuse comprenant une statine |
| JP5647379B2 (ja) | 2011-07-22 | 2014-12-24 | ファイザー・インク | キノリニルグルカゴン受容体モジュレーター |
| DE102012208530A1 (de) | 2012-05-22 | 2013-11-28 | Bayer Pharma AG | Substituierte Piperidinoacetamide und ihre Verwendung |
| PL3013796T3 (pl) * | 2013-06-27 | 2020-06-15 | Lg Chem, Ltd. | Pochodne biarylowe jako agoniści gpr120 |
| JO3425B1 (ar) | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| CA2944617A1 (fr) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | Derives chiraux d'acide cyclopentanecarboxylique a disubstitution 2,5 et leur utilisation |
| WO2015150363A1 (fr) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | Acides cyclopentanecarboxyliques à disubstitution 2,5 et leur utilisation |
| EP3126358A1 (fr) | 2014-04-03 | 2017-02-08 | Bayer Pharma Aktiengesellschaft | Acides cyclopentanecarboxyliques à disubstitution 2,5 pour traiter des maladies des voies respiratoires |
| BR112016030690B1 (pt) | 2014-06-27 | 2023-11-14 | Nogra Pharma Limited | Compostos moduladores do receptor de arila, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos |
| CR20170258A (es) | 2014-12-18 | 2017-07-21 | Bayer Pharma AG | Ácidos piridil-cicloalquil-carboxílicos sustituidos, composiciones que los contienen y usos de los mismos. |
| US10905667B2 (en) | 2018-07-24 | 2021-02-02 | Bayer Pharma Aktiengesellschaft | Orally administrable modified-release pharmaceutical dosage form |
| CN116693514A (zh) * | 2022-03-01 | 2023-09-05 | 上海璎黎药业有限公司 | 一类芳香环取代的甲氧基衍生物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4243678A (en) * | 1977-12-30 | 1981-01-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Acylhydrocarbylaminoalkanoic acids, compositions and uses |
| JPS59141540A (ja) * | 1983-02-01 | 1984-08-14 | Chisso Corp | 三環カルボン酸エステル誘導体 |
| CZ288974B6 (cs) * | 1992-03-19 | 2001-10-17 | Eli Lilly And Company | Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití |
| US5786325A (en) * | 1995-05-26 | 1998-07-28 | Eli Lilly And Company | Cyclic peptide antifungal agents and methods of making and using |
| EP0893731B1 (fr) * | 1997-07-25 | 2004-01-28 | Eastman Kodak Company | Couche d'émulsion à l'halogénure d'argent sensible à la lumière ayant une sensibilité photographique améliorée |
| DE19907904A1 (de) * | 1999-02-24 | 2000-08-31 | Clariant Gmbh | Verfahren zur Herstellung von [1,1':4',1"]-Terphenylverbindungen |
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| CA2404226A1 (fr) | 2000-03-23 | 2001-09-27 | Takeda Chemical Industries, Ltd. | Derives de furoisoquinoleine, leur procede de production et leur utilisation |
| JP4105446B2 (ja) * | 2002-02-20 | 2008-06-25 | 富士フイルム株式会社 | 重合性化合物およびそのマトリックスを用いた光学素子 |
-
2004
- 2004-04-30 US US10/835,924 patent/US7524878B2/en not_active Expired - Fee Related
- 2004-04-30 EP EP04751193A patent/EP1620422A2/fr not_active Withdrawn
- 2004-04-30 CN CNA2004800184175A patent/CN1812978A/zh active Pending
- 2004-04-30 CA CA002524235A patent/CA2524235A1/fr not_active Abandoned
- 2004-04-30 AU AU2004236248A patent/AU2004236248A1/en not_active Abandoned
- 2004-04-30 EA EA200501713A patent/EA200501713A1/ru unknown
- 2004-04-30 WO PCT/US2004/013701 patent/WO2004099170A2/fr not_active Ceased
- 2004-04-30 BR BRPI0409916-8A patent/BRPI0409916A/pt not_active IP Right Cessation
- 2004-04-30 JP JP2006514244A patent/JP2006525365A/ja active Pending
- 2004-04-30 MX MXPA05011536A patent/MXPA05011536A/es not_active Application Discontinuation
- 2004-04-30 KR KR1020057020623A patent/KR20060006954A/ko not_active Withdrawn
-
2005
- 2005-11-02 NO NO20055129A patent/NO20055129L/no not_active Application Discontinuation
- 2005-11-29 ZA ZA200509635A patent/ZA200509635B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7524878B2 (en) | 2009-04-28 |
| AU2004236248A1 (en) | 2004-11-18 |
| US20050004369A1 (en) | 2005-01-06 |
| EP1620422A2 (fr) | 2006-02-01 |
| CA2524235A1 (fr) | 2004-11-18 |
| EA200501713A1 (ru) | 2006-06-30 |
| MXPA05011536A (es) | 2006-01-23 |
| WO2004099170A3 (fr) | 2005-09-15 |
| NO20055129D0 (no) | 2005-11-02 |
| CN1812978A (zh) | 2006-08-02 |
| KR20060006954A (ko) | 2006-01-20 |
| BRPI0409916A (pt) | 2006-04-25 |
| ZA200509635B (en) | 2007-04-25 |
| JP2006525365A (ja) | 2006-11-09 |
| WO2004099170A2 (fr) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055129L (no) | Fenylsubstituerte karboksylsyrer | |
| NO20054958L (no) | Substitulerte aminokarboksylsyrer | |
| NO20054769L (no) | Substituerte fenylalkansyrer | |
| NO20054957L (no) | Subtituerte karboksylsyrer | |
| ATE372324T1 (de) | Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen | |
| MXPA05011539A (es) | Acidos carboxilicos sustituidos con heterociclo como inhibidores de la proteina tirosina-fosfatasa-1b. | |
| TW200630327A (en) | Substituted phenylalkanoic acids | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| WO2007089857A3 (fr) | Derives d'imidazole a substitution, compositions et procedes d'utilisation en tant qu'inhibiteurs de ptpase | |
| WO2006055708A3 (fr) | Acides carboxyliques a substitution heterocyclique | |
| WO2008033932A3 (fr) | Acides carboxyliques de biarylthiazole | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| EP1562897A4 (fr) | Inhibiteurs de beta-secretase phenylcarboxamide utilises dans le traitement de la maladie d'alzheimer | |
| BR0310106A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica | |
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| BRPI0515489A (pt) | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase | |
| BRPI0515483A (pt) | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase | |
| WO2004071448A3 (fr) | Derives d'azole substitues comme agents therapeutiques | |
| EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
| EP2091328A4 (fr) | Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| WO2006055725A3 (fr) | Acides amino carboxyliques substitues | |
| EP1817312A4 (fr) | Inhibiteurs de l'aminopyridyle de la beta-secretase macrocyclique permettant de traiter la maladie d'alzheimer | |
| EP2077719A4 (fr) | Inhibiteurs pipéridines et pyrrolidines de la bêta-secrétase utilisés dans le traitement de la maladie d'alzheimer | |
| ATE520691T1 (de) | Shp-2-hemmer, pharmazeutische zusammensetzung damit und ihre verwendung zur behandlung phosphatase-vermittelter erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |